1
|
Haneishi T, Kato Y, Fukuda H, Shimamura T, Tanokura T, Hiraide A, Koyama K, Fudesaka M, Maeda K, Nakata N, Nagase M, Yabuzaki T, Takao H, Kigawa M, Shimizu H, Shimizu M. Development of a Kilogram-Scale Synthesis of a Novel Anti-HCV Agent, CH4930808. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.7b00383] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Tsuyoshi Haneishi
- Research
Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
| | - Yoshiaki Kato
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Hiroshi Fukuda
- Research
Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
| | - Tomoyuki Shimamura
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Takemi Tanokura
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Akira Hiraide
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Kaichiro Koyama
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Masato Fudesaka
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Kenji Maeda
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Nobuyuki Nakata
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Masahiro Nagase
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Takahiko Yabuzaki
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Hiroaki Takao
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Masaharu Kigawa
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Hitoshi Shimizu
- Pharmaceutical
Technology Division, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan
| | - Makoto Shimizu
- Department
of Chemistry for Materials, Graduate School of Engineering, Mie University, Tsu, Mie 514-8507, Japan
| |
Collapse
|
2
|
Murakata M, Ikeda T. Stereoselective synthesis of the viridiofungin analogue NA808 from a chiral tetrahydrofuran-carboxylic acid. Org Biomol Chem 2017; 15:6632-6639. [PMID: 28752880 DOI: 10.1039/c7ob01608e] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The viridiofungin analogue NA808 was synthesized by the stereoselective Ireland-Claisen rearrangement of dienylmethyl ester, regioselective bromolactonization of β-divinylpropanoic acid and retro-bromolactonization.
Collapse
Affiliation(s)
- Masatoshi Murakata
- API Process Development Department, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-Ku, Tokyo 115-8543, Japan.
| | | |
Collapse
|